Sign In
Buy XLV
$162.55
-0.97 (-0.593%)
At Close: Jul 31, 2026
3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List
04:05pm, Monday, 17'th Nov 2025
The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
05:25am, Monday, 17'th Nov 2025
Several large-cap drugmakers have been climbing and are bringing the sector higher. There's also a flight to safety, as investors reallocate funds from high-flying tech stocks.
If M&A continues at this pace you want to be long Biotech into next year, says Mizuho's Jared Holz
06:17pm, Friday, 14'th Nov 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk the uptick in biotech and pharma M&A, what it is signaling, and how to play it.
Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman
03:19pm, Friday, 14'th Nov 2025
Evan Seigerman, BMO Capital Markets head of health care research, joins 'Power Lunch' to discuss what's behind the recent move in health care stocks, the state of play with GLP-1s and much more.
'Fast Money' traders talk how to play biopharma space
06:56pm, Tuesday, 11'th Nov 2025
The 'Fast Money' traders talk how to play biopharma space.
Senate's Deal Signals Potential End to US Govt. Shutdown: Top ETFs to Buy
08:50am, Monday, 10'th Nov 2025
A bipartisan Senate deal signals an end to the U.S. government shutdown, sparking investor interest in ETFs like XLV and SPY.
Momentum and private assets: The trends driving ETFs to record inflows
04:59pm, Wednesday, 05'th Nov 2025
ETF inflows are already at record annual flows. Todd Rosenbluth, VettaFi head of research, on what's driving the momentum and the trends that are standing out.
Schwab IMPACT 2025: Record $13T in ETFs & What's Next for ETF Assets
11:44am, Wednesday, 05'th Nov 2025
Matt Camuso, Head of ETF Solutions at BNY Investments, says there are $13 trillion of assets in ETFs. That's compared to $5 trillion a year prior.
2 Classic ETFs Were Back in Favor in October
07:33am, Monday, 03'rd Nov 2025
State Street Investment Management (SSIM) is home to the lowest-cost S&P 500 ETF — the SPDR Portfolio S&P 500 ETF (SPYM) — and the largest gold ETF, SPDR Gold Shares (GLD). Though these two ETFs h
4 Sector ETFs & Stocks to Gain Despite Lower-Than -Expected Inflation
08:16am, Monday, 27'th Oct 2025
September records lower-than-expected inflation! Energy (OIH), Restaurants (EATZ), Healthcare (XLV) and Transportation (XTN) ETFs may still shine in the near term.
The Utterly Tranquil Feeling Of Watching Your Passive Income Grow
08:15am, Saturday, 25'th Oct 2025
Dividend growth investing offers reliable, passive income and personal tranquility, more so than non-dividend strategies and rental property investing. Current market valuations, especially in Big Tec
Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs
12:36pm, Friday, 24'th Oct 2025
Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs.
Health Care Select Sector SPDR Fund Target of Unusually Large Options Trading (NYSEARCA:XLV)
02:39am, Thursday, 23'rd Oct 2025
Health Care Select Sector SPDR Fund (NYSEARCA:XLV - Get Free Report) was the target of unusually large options trading activity on Wednesday. Traders purchased 27,150 call options on the stock. This r
October's 5 Dividend Growth Stocks With Yields Up To 8.33%
11:34am, Monday, 20'th Oct 2025
Every month, we screen for high-yield dividend yields, but those that also deliver relatively consistent growth with regular dividend increases. The parameters of the screening also include dividend s
XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way
01:21am, Saturday, 18'th Oct 2025
The Fed has begun to reduce interest rates in the U.S. This decision will incentivize the deployment of funding in the healthcare industry. The top holdings of XLV are profitable firms, with a median
